QuanDx – Molecular Diagnostics Innovator
- Stay in touch with us via Facebook/Twitter/ Linkedin/InstagramClick icons on the bottom right.
- QuanDx/Zeesan Biotech’s MeltPro High Risk HPV Genotyping Assay is Effective for Cervical Cancer Screening for Women in Low- and Middle-Income CountriesCustomer StoryQuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment...QuanDx Announces Raising $3.0 Million in Series B2 FinancingQuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment...
Learn more about the products we offer.
Leukemia Fusion Gene
Fusion gene detection kits offer simultaneous, cost-effective detection of fusion genes for leukemia diagnosis, stratification, and monitoring.
QuanDx’s melting curve analysis technology delivers rapid, accurate detection of High-Risk HPV and Drug-Resistant Tuberculosis.
QuanDx offers state of the art instruments for PCR applications and nucleic acid extraction.